Brittney Browne
Acute Care · Monroe, OHNPI 1710401047
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (53.2%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Gilead at 51.8% of the total. Reporting peaked in 2022 at $61,840 and has fallen 97.1% since, to $1,807 in 2024. Among acute care clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 263 payments — averaging $539.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$73K
- E.r. Squibb & Sons, L.L.C.$43K
- Bristol Myers Squibb$24K
- Pharmacyclics LLC, An Abbvie Company$204
- Pharmacosmos Therapeutics Inc.$135
- Johnson & Johnson$132
- plus $975 from 16 others
What the payments were for
- Consulting fees$3,0902%
- Speaking & faculty fees$75,48053%
- Travel & lodging$55,99239%
- Food & beverage$7,0535%
- Education$1980%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 98 | $73,432 |
| E.r. Squibb & Sons, L.L.C. | 71 | $42,814 |
| Bristol Myers Squibb | 44 | $24,122 |
| Pharmacyclics LLC, An Abbvie Company | 10 | $204 |
| Pharmacosmos Therapeutics Inc. | 1 | $135 |
| Johnson & Johnson | 7 | $132 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $128 |
| Adaptive Biotechnologies Corporation | 1 | $124 |
| Seagen Inc. | 2 | $118 |
| AbbVie | 2 | $106 |
| Janssen Scientific Affairs, LLC | 1 | $90 |
| Jazz Pharmaceuticals Inc. | 6 | $88 |
| Morphosys, US Inc. | 2 | $76 |
| Astellas Pharma US Inc | 4 | $64 |
| Incyte Corporation | 3 | $48 |
| Dova Pharmaceuticals | 2 | $39 |
| Pfizer | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Beigene USA, Inc. | 1 | $16 |
| Kadmon Pharmaceuticals LLC | 1 | $15 |
| Amgen | 1 | $14 |
| AstraZeneca | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$141,813 in reported general payments places this provider in the 95th percentile of 1,101 acute care providers in Ohio.
Other acute care in Monroe
- Andrea RobinsonCleveland$149K
- Jamie McGuireMiamisburg$86K
- Ileah ReichertColumbus$73K
- Davida PraterBeavercreek$46K
- Dawn FrenchAlliance$40K
- Holly McKibbenColumbus$23K
- Jody HussBlue Ash$13K
- Julie LurieCincinnati$13K
- Susan BrooksMount Vernon$11K
- Laura WellsChillicothe$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.